Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC62957 Eriodictyol-7-O-glucoside A flavanone glucoside with diverse biological activities
  3. GC62936 Dimethyl fumarate D6 Dimethyl fumarate D6 是 Dimethyl fumarate 的氘代标记物。Dimethyl fumarate 是一种 Nrf2 激活剂,能够诱导上调抗氧化基因的表达。
  4. GC62927 Desmethylxanthohumol Desmethylxanthohumol 是一种从啤酒花球果 (Humulus lupulus L.) 中分离的烯丙基化羟基查耳酮。Desmethylxanthohumol 是一种强大的凋亡 (apoptosis) 诱导剂,具有抗血浆,抗增殖和抗氧化的生物活性。
  5. GC62871 BM-1244 BM-1244 是一种有效的 Bcl-xL/Bcl-2 抑制剂,对 Bcl-xL 和 Bcl-2 的Ki 分别为 134 和 450 nM。BM-1244 抑制衰老成纤维细胞 (SnCs),EC50 为 5 nM。
  6. GC49437 Gliotoxin-13C13 An internal standard for the quantification of gliotoxin
  7. GC49431 Simazine A triazine herbicide
  8. GC49429 6-keto Lithocholic Acid A metabolite of lithocholic acid
  9. GC49426 Taurine-d4 An internal standard for the quantification of taurine
  10. GC49425 Simazine-d10 An internal standard for the quantification of simazine
  11. GC49415 Capsorubin A carotenoid with diverse biological activities
  12. GC49412 NSC 756093 An inhibitor of the GBP1-Pim-1 protein-protein interaction
  13. GC49403 Benzarone An active metabolite of benzbromarone
  14. GC49401 Triptolide-d3 Triptolide-d3 (PG490-d3) 是氘标记的雷公藤内酯。雷公藤内酯是从雷公藤根中提取的二萜类三环氧化物,具有免疫抑制、抗炎、抗增殖和抗肿瘤作用。雷公藤内酯是一种 NF-κB 活化抑制剂。
  15. GC49393 all-trans-13,14-Dihydroretinol A metabolite of all-trans retinoic acid
  16. GC49372 Kaempferol 7-neohesperidoside A flavonoid glycoside with antioxidant and anticancer activities
  17. GC49344 Fisetin-d5 An internal standard for the quantification of fisetin
  18. GC49329 Turkesterone (hydrate) A phytoecdysteroid with diverse biological activities
  19. GC49314 Arecaidine propargyl ester (hydrobromide) A muscarinic M2 agonist
  20. GC49308 Ungeremine A betaine-type alkaloid with diverse biological activities
  21. GC49303 Ganoderic Acid DM A triterpenoid with diverse biological activities
  22. GC49275 8-Oxycoptisine An isoquinoline alkaloid with anticancer and gastroprotective activities
  23. GC49270 Nicotinamide-d4 An internal standard for the quantification of nicotinamide
  24. GC49268 (+)-δ-Cadinene A sesquiterpene with antimicrobial and anticancer activities
  25. GC49259 Antagonist G (trifluoroacetate salt) A neuropeptide antagonist
  26. GC49251 Oxaliplatin-d10 An internal standard for the quantification of oxaliplatin
  27. GC49228 Ganoderol B A triterpenoid with diverse biological activities
  28. GC49223 2-deoxy-D-Glucose-13C6 An internal standard for the quantification of 2-deoxy-D-glucose
  29. GC49221 QLT0267 An ILK inhibitor
  30. GC49189 (E/Z)-4-hydroxy Tamoxifen-d5 An internal standard for the quantification of (E/Z)-4-hydroxy tamoxifen
  31. GC49177 Loliolide A monoterpene lactone with diverse biological activities
  32. GC49168 Visnagin A furanochromone with diverse biological activities
  33. GC49164 DM4 (hydrate) A derivative of maytansine
  34. GC49155 K6PC-5 An SPHK1 activator
  35. GC49153 Didemnin B A depsipeptide with diverse biological activities
  36. GC49152 Celecoxib Carboxylic Acid An inactive metabolite of celecoxib
  37. GC49147 Carboxyphosphamide An inactive metabolite of cyclophosphamide
  38. GC49137 Triclabendazole-13C-d3 An internal standard for the quantification of triclabendazole
  39. GC49130 Hydroxy Celecoxib An inactive metabolite of celecoxib
  40. GC49127 4-oxo Cyclophosphamide An inactive metabolite of cyclophosphamide
  41. GC49126 Folitixorin A reduced form of folate and cofactor for thymidylate synthetase
  42. GC49096 Cobaltic Protoporphyrin IX (chloride) An inducer of HO-1 activity
  43. GC49084 PHY34 An inhibitor of late-stage autophagy
  44. GC49080 CAY10786 A GPR52 antagonist
  45. GC49055 Tebuconazole-d9 An internal standard for the quantification of tebuconazole
  46. GC49042 Benastatin A A bacterial metabolite with diverse biological activities
  47. GC49024 Palmitic Acid MaxSpec® Standard A long-chain saturated fatty acid
  48. GC49023 Palmitic Acid-d9 MaxSpec® Standard A quantitative analytical standard guaranteed to meet MaxSpec identity, purity, stability, and concentration specifications
  49. GC49015 Phenethyl isothiocyanate An isothiocyanate with anticancer activity
  50. GC48974 Ac-VEID-AMC (ammonium acetate salt) A caspase-6 fluorogenic substrate
  51. GC48971 AZD 1152 (hydrochloride) A prodrug for a potent Aurora B inhibitor

Items 301 to 350 of 2286 total

per page
  1. 5
  2. 6
  3. 7
  4. 8
  5. 9

Set Descending Direction